Reach the investors backing rounds like this
Backed by L'Oréal, Walgreens · verified emails and LinkedIn on Datapile
L'Oréal, Walgreens back China biomaterials startup PAM2L in $30M round - Dealroom
PAM2L is a China-based biomaterials startup that has raised $30 million in a new funding round. The company is backed by L'Oréal and Walgreens, indicating significant interest in its innovative approach to biomaterials. This funding will likely accelerate PAM2L's development and commercialization efforts in the growing biomaterials market.
L'Oréal, Walgreens back China biomaterials startup PAM2L in $30M round Dealroom
| Nov 13, 2026 | Xilect | $68K | — | China |
| Nov 12, 2026 | CMOC | $243.0M | Debt | China |
| Nov 11, 2026 | FitX | $30.0M | Angel | China |
| Nov 09, 2026 | Chuangxiang Yuedong | $8.3M | Seed | China |
You just read who funded PAM2L. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.